Related Experiment Video
Updated: Jun 5, 2025

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
A Multisynergistic Strategy for Bone Tumor Treatment: Orchestrating Oxidative Stress and Autophagic Flux Inhibition
Xiaochen Chen1, Pengfei Tian2, Wenwen Chai1,2
1School of materials science and engineering, Tongji University, Shanghai, 201804, P.R. China.
Abstract:
Tumor therapy has advanced significantly in recent years, but tumor cells can still evade and survive the treatment through various mechanisms. Notably, tumor cells use autophagy to sustain viability by removing impaired mitochondria and clearing excess reactive oxygen species (ROS). In this study, the aim is to amplify intracellular oxidative stress by inhibiting mitochondrial autophagic flux. Multisynergistic environmental-response nanoparticles (ERNs) are engineered by integrating gold nanoparticles and copper peroxide with borosilicate bioactive glass. The controlled release of copper and inhibition of autophagy flux triggered an overabundance and accumulation of oxidative stress within the tumor cells. This stress triggered immunogenic tumor cell death, believed to initiate a systemic immune response. The tumor microenvironment (TME) transitioned back to a normal physiological state as tumor cells are ablated. ERNs responded to the microenvironment changes by depositing hydroxyapatite on the surface and spontaneously enhancing bone regeneration. This innovative formulation facilitates the functional transition of ERNs from "anti-tumor therapy" to "biomineralization" that kills cancers and induces new bone formation. Overall, it is shown that the ERNs effectively eradicate cancers by utilizing chemodynamic therapy, starvation therapy, and immunotherapy.
Insights
This study introduces environmental-response nanoparticles (ERNs) that kill tumor cells by increasing oxidative stress and triggering an immune response. The nanoparticles also promote bone regeneration after cancer eradication, transitioning from anti-tumor therapy to biomineralization.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Therapy
Background:
- Tumor cells evade therapy via mechanisms like autophagy, which clears damaged mitochondria and reactive oxygen species (ROS).
- Inhibiting autophagy can enhance oxidative stress, potentially leading to cancer cell death and immune responses.
Purpose of the Study:
- To engineer novel nanoparticles that amplify intracellular oxidative stress by inhibiting mitochondrial autophagic flux.
- To investigate the dual function of these nanoparticles in cancer eradication and bone regeneration.
Main Methods:
- Development of multisynergistic environmental-response nanoparticles (ERNs) integrating gold nanoparticles, copper peroxide, and borosilicate bioactive glass.
- Controlled release of copper and inhibition of autophagy flux within tumor cells.
- Observation of nanoparticle response to tumor microenvironment changes, including hydroxyapatite deposition and bone regeneration.
Main Results:
- ERNs induced significant accumulation of oxidative stress, leading to immunogenic tumor cell death and a systemic immune response.
- The tumor microenvironment normalized post-treatment, with ERNs promoting bone regeneration.
- Effective cancer eradication demonstrated through combined chemodynamic therapy, starvation therapy, and immunotherapy.
Conclusions:
- Environmental-response nanoparticles (ERNs) offer a novel dual-action therapeutic strategy against cancer.
- ERNs effectively kill cancer cells by inducing oxidative stress and initiating immunotherapy.
- The nanoparticles facilitate a functional transition from anti-tumor therapy to biomineralization, promoting bone formation.
More Related Videos
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...